To boost diversity in clinical trials, NIH takes to the road to collect DNA from underrepresented groups
During the pandemic, the effort suspended in-person recruiting and lost momentum.
The Black woman's cells, taken in 1951 without her consent, spurred medical advances worth billions. Now a judge has to decide if her family is entitled to a share of the profits.
With lockdown measures in place, that meant people were limiting their interactions with others.
Eight percent of doctors have closed their practices because of COVID-19, and a quarter are considering retiring early.
Prosthetic limbs are essential for many people. But they are also expensive. One possible solution? Technology.
President Trump is expected to call for an end to HIV transmission by 2030. The drug known as PrEP may be key.
The giant multinational corporation Bayer is selling off the Dr. Scholl’s and Coppertone brands acquired four years ago when the company bought Merck. Now Bayer is looking to expand its cancer drug research and development and the agribusinesses it’s been growing since buying Monsanto earlier this year. Sounds good, but there’s a lingering problem that […]
It's "really about returning excess profits," a Kaiser Family Foundation executive says.
Drug companies can get creative with doctor incentives, and that can be problematic.